General, MS News Siponimod recommended for secondary progressive MS by EMA Written by Ellen on November 20th, 2019December 8th, 2021. The European Medicines Agency has recommended that a licence should be granted forĀ SiponimodĀ for the treatment of active secondary progressive MS.